Deep dive into rare mouth cancer could unlock personalized treatments
NCT ID NCT07662694
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at a rare type of cancer called oral mucosal melanoma. Researchers want to improve how the cancer is staged by measuring how deep it goes into tissue and by studying its genetic makeup. They will follow 1,100 patients over time to see which treatments work best for different tumor types. The goal is to create a more precise system for guiding therapy and predicting outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to more accurate staging and personalized treatments for oral mucosal melanoma, potentially improving survival.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test new therapies. Results may not apply to non-Chinese populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUCOSAL MELANOMA OF THE HEAD AND NECK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,
Shanghai, Shanghai Municipality, 200011, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.